Research Analysts Set Expectations for CMPX Q1 Earnings
Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) – Investment analysts at HC Wainwright issued their Q1 2025 earnings estimates for shares of Compass Therapeutics in a research note issued to investors on Thursday, February 27th. HC Wainwright analyst J. Pantginis anticipates that the company will post earnings per share of ($0.11) for the quarter. HC […]
